Ottobock has acquired the functional electrical stimulation (FES) product portfolio of Fesia Technology to broaden its neuro-orthotics offerings [1, 2].
This move strengthens the company's presence in the neurorehabilitation market, providing advanced tools for patients attempting to regain lost physical functions. By integrating FES technology, Ottobock aims to offer more comprehensive solutions for motor impairment recovery.
Functional electrical stimulation involves the use of small electrical pulses to activate muscles that have been paralyzed or weakened due to neurological conditions. According to a statement from Ottobock, these products are used in neurorehabilitation to help patients regain movement and function [1].
"This acquisition will significantly expand Ottobock’s neuro-orthotics portfolio and strengthen its position in the functional electrical stimulation market," Hans Peter Landgraf, Ottobock CEO, said [1].
The deal was originally announced on Nov. 9, 2023 [1]. While the integration process has since progressed, the acquisition was expected to close in the first quarter of 2024 [3], pending the necessary regulatory approvals.
Ottobock's strategic focus on neuro-orthotics reflects a broader industry trend toward combining mechanical bracing with active electrical stimulation. This hybrid approach allows for more dynamic patient care than traditional passive orthotics alone.
“"This acquisition will significantly expand Ottobock’s neuro-orthotics portfolio"”
The integration of Fesia Technology's FES portfolio allows Ottobock to move beyond passive support devices into active neuromodulation. This shift suggests a strategic pivot toward a more holistic rehabilitation model where electrical stimulation and orthotic support work in tandem to accelerate patient recovery.
